Consilium Strategic Communications has been appointed by specialty pharmaceutical firm Allergy Therapeutics as its international investor relations advisor.
The healthcare agency will support Allergy Therapeutics’ international financial and corporate public relations activities as it seeks to step up its international stakeholder activities.
Consilium’s Mary-Jane Elliott, Chris Gardner, Ivar Milligan, Matthew Neal and Laura Thornton have been tasked with raising the European allergy product company’s global profile, particularly focusing on the US.
Commenting on the Consilium advisory team, Allergy Therapeutics’ chief executive officer Manuel Llobet said: “This team’s expertise and knowledge of the sector is unrivalled and they have already demonstrated this through their high quality advice, proactivity and professionalism.”
Elliott, co-founder and managing partner at Consilium, said: “We are delighted to be advising Allergy Therapeutics at a time when they are on a steep growth trajectory due to a strong portfolio of marketed products and M&A.
“We look forward to accompanying them on their journey as they pave the way to the US market and further international growth.”